Glenmark Pharmaceuticals gets final approval for Tretinoin Capsules
From USFDA
Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (USFDA) for Tretinoin Capsules, 10 mg, the generic version of Vesanoid Capsules, 10 mg, of Hoffmann La Roche, Inc. (which is no longer being marketed in the United States).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content